Dear Boyd Street Community,
Welcome to our Q2 2026 Newsletter, which includes the following features:Opening NoteQ2 at a GlanceFirm HighlightsLeadership & Governance ExpansionStrategic Platform DevelopmentEvents & Industry EngagementPortfolio HighlightsLooking AheadWe hope you enjoy this issue!
Opening Note
Q2 represented one of the most transformational quarters in Boyd Street Capital's history.While continuing to support and grow our existing portfolio, we reached several major strategic milestones that position the firm for its next phase of growth. During the quarter, we advanced the development of HealthTech Platform Fund II, expanded our executive leadership team, strengthened our Board of Directors, continued building Boyd Street Capital and deepened relationships with leading healthcare systems, research institutions, corporate partners, and institutional investors.
Fund I also continued to make meaningful progress, with portfolio companies achieving important commercial, clinical, and operational milestones while several investments advanced through strategic financing, partnership, and exit-readiness initiatives.Our strategy is built around a simple principle: promising companies require more than capital.
By combining investment expertise with clinical validation, commercialization support, institutional partnerships, and operating resources, Boyd Street seeks to help companies become more scalable, strategically relevant, and valuable. As we continue expanding our platform, we remain focused on creating long-term value for founders, investors, and strategic partners alike.
Connect with Our Investment Team
Q2 at a Glance
Firm Highlights
Boyd Street Capital Continues to GrowFollowing the launch of Boyd Street Capital earlier this year, Q2 focused on strengthening the infrastructure, leadership, and strategic relationships supporting our long-term vision.Boyd Street Capital is being built as a multi-strategy investment platform comprising Boyd Street Ventures, the healthcare-focused HealthTech Platform Fund II, and a developing Lower Middle Market Capital Access strategy.
Together, these strategies are designed to support companies from venture formation and commercialization through strategic growth and long-term value creation.During the quarter we:Expanded our executive leadership team with experienced healthcare and investment leaders.Advanced our Lower Middle Market Capital Access strategy.Refined the structure and strategic partnerships supporting HealthTech Platform Fund II.Strengthened our operating platform to better support founders beyond capital.These milestones reinforce our long-term vision of building a differentiated investment platform that combines venture capital, strategic partnerships, commercialization expertise, and operational support.
Leadership and Governance Expansion
As Boyd Street Capital continues to grow, we welcomed several outstanding leaders to support our next phase of expansion.
Kurt Lee joined as Chief Platform Officer, leading platform strategy, venture studio operations, portfolio support, and commercialization initiatives.
Lisa Risser, CPA, MBA, FACHE, FHFMA joined as General Partner of HealthTech Platform Fund II, bringing decades of healthcare leadership and commercialization experience.
Nicholas Browner joined as General Partner of Boyd Street Capital, leading our Capital Access strategy focused on founder-led lower middle market businesses.
Nina Hoch, CFA assumed expanded responsibilities supporting strategic finance initiatives and firm-wide financial planning.
We also strengthened our governance with the appointment of Laura Click as a Board Observer. Laura brings more than three decades of executive leadership experience spanning corporate communications, government relations, strategy, operations, commercialization, and business development. She specializes in helping organizations strengthen their brands, build strategic partnerships, and communicate complex ideas with clarity.
Her expertise further strengthens our Board as we continue expanding our national healthcare investment platform.Together, these additions significantly enhance Boyd Street Capital's ability to support founders while executing our long-term strategy.
Strategic Platform Development
HealthTech Platform Fund IIOne of the most significant accomplishments during Q2 was the continued development of HealthTech Platform Fund II.Designed as a healthcare-focused investment platform, the fund combines institutional capital with strategic partnerships to accelerate healthcare innovation and commercialization.
The platform is designed to address one of healthcare innovation's most persistent challenges: connecting promising technologies with the clinical environments, commercialization expertise, strategic customers, and growth capital required for successful adoption.
During the quarter we:
Advanced strategic discussions with Mayo Clinic.
Expanded relationships with leading health systems.Strengthened engagement with research institutions.Grew our national commercialization ecosystem.Refined governance, fund economics, and operating framework.
The platform is built around five strategic partner groups:
Health Systems Research
Institutions Innovation
Commercialization Partners
Corporate PartnersStrategic
Capital Partners
HealthTech Platform Fund II represents more than an investment fund.
It is a collaborative platform designed to accelerate healthcare innovation through clinical validation, commercialization, strategic partnerships, and long-term capital.
Events & Industry Engagement
Throughout Q2, Boyd Street Capital engaged with healthcare leaders, institutional investors, founders, research organizations, and strategic partners across the United States and internationally.
Highlights included: Executive meetings across Norman, Dallas, Houston, Amsterdam, London, Geneva, and Doha, strengthening relationships with investors, healthcare organizations, and strategic partners.
Continued engagement with research institutions and commercialization partners supporting healthcare innovation.Ongoing discussions with institutional investors regarding Boyd Street Capital and HealthTech Platform Fund II.
Participation in healthcare, venture capital, and private investment conferences throughout the quarter.These engagements continue expanding Boyd Street Capital's national and international network while creating new opportunities for our portfolio companies and strategic partners.
Portfolio Highlights
Across the portfolio, our companies continued to make meaningful progress through commercialization, strategic partnerships, market expansion, financing activities, and industry recognition.
Lumata Health – Expanding Access to Vision Care Lumata Health continued expanding its national footprint, now supporting more than 27,000 patients through partnerships with leading healthcare organizations. The company remains focused on improving patient outcomes by increasing adherence to vision care and helping prevent avoidable blindness through innovative care navigation. During the quarter, Lumata also continued advancing its next stage of growth through strategic financing initiatives and expanded engagement with investors.
Myri Health – Expanding Global Reach in Maternal Health Myri Health continued building momentum during Q2 with several significant milestones in women's health innovation. The company was selected for both the Qatar Science & Technology Park (QSTP) × Merck FemTech Accelerator and the Organon META Women's Health Accelerator, expanding opportunities for international collaboration around maternal health, AI-enabled care navigation, and remote patient monitoring. Founder & CEO Dr. Pinkey Patel also joined the Milken Institute Women's Health Network, while Myri was nominated for Best FemTech Product of the Year at the 2026 MedTech World Awards.
VesprSolar – Advancing Next-Generation Energy Solutions VesprSolar continued advancing commercialization efforts during Q2 while expanding strategic relationships across the energy sector. The company made meaningful progress toward its next stage of growth through continued engagement with industry partners as it develops its next-generation solar technology platform. Boyd Street Ventures also continued supporting the company's financing strategy and commercialization efforts as VesprSolar prepares for its next financing round and broader market adoption.
Looking Ahead
As we move into the second half of 2026, our priorities remain focused on disciplined execution and long-term value creation.Key initiatives include: Completing Fund I final close activities.
Advancing the first close of HealthTech Platform Fund II.
Continuing portfolio company commercialization and operational support. Expanding strategic partnerships across the HealthTech Platform.
Supporting select portfolio companies through strategic financing and exit preparation.
Continuing to grow Boyd Street Capital's Lower Middle Market Capital Access strategy.
We remain committed to building a differentiated investment platform that delivers lasting value for entrepreneurs, investors, healthcare partners, and the communities we serve.
"Healthcare innovation does not suffer from a shortage of ideas. The larger challenge is connecting innovation with validation, adoption, operating expertise, and appropriately structured capital. That is the platform Boyd Street is building."— James Spann, Founder & Chief Executive OfficerConnect with Boyd Street Capital!
As we continue building the Boyd Street Capital platform, we welcome conversations with:
Institutional Investors
Healthcare Systems
Research Institutions
Corporate Partners
Founders
Family-Owned Businesses
Connect with Our Investment Team
Thank You!
We appreciate your continued interest in and support of Boyd Street Capital.We look forward to sharing additional updates as we continue executing our long-term strategy and building the next chapter of our firm.
T
hanks for checking in!
Best,James H. Spann, Jr.
Founder and Chief Executive Officer
Boyd Street Capital,
LLCCopyright (C) 2026 Boyd Street Capital. All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
331 W. Boyd Street, Norman, OK 73069
Want to change how you receive these emails?
You can update your preferences or unsubscribeYou are receiving this email because you opted in via our website.
Our mailing address is:
331 W. Boyd Street, Norman, OK 73069
